4-Aminopyridyl-Based CYP51 Inhibitors as Anti-Trypanosoma cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency
暂无分享,去创建一个
J. Gut | J. McKerrow | M. Cameron | W. Roush | C. M. Calvet | J. Siqueira-Neto | D. Kellar | Jonathan B. Johnston | J. Choi | Li Lin | Susan Khan | L. Podust | D. F. Vieira | Danielle Kellar